BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9832070)

  • 1. Interleukin 6 and its soluble receptor in periodontitis.
    Pietruska M; Pietruski JK; Stokowska W; Jabłońska E
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):305-9. PubMed ID: 9832070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis.
    Górska R; Gregorek H; Kowalski J; Laskus-Perendyk A; Syczewska M; Madaliński K
    J Clin Periodontol; 2003 Dec; 30(12):1046-52. PubMed ID: 15002890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis.
    Goutoudi P; Diza E; Arvanitidou M
    J Dent; 2004 Sep; 32(7):511-20. PubMed ID: 15304296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K
    Med Sci Monit; 2001; 7(5):914-8. PubMed ID: 11535934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor.
    De Jongh R; Vranken J; Vundelinckx G; Bosmans E; Maes M; Heylen R
    Cytokine; 1997 Sep; 9(9):696-701. PubMed ID: 9325019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse correlation of interleukin-6 with soluble interleukin-6 receptor after transplantation of bone marrow or peripheral blood stem cells.
    Steffen M; Pichlmeier U; Zander A
    Bone Marrow Transplant; 1997 Nov; 20(9):715-20. PubMed ID: 9384472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Examination and evaluation of sIL-6R, sgp130 in serum in patients with chronic hepatopathy].
    Shang J; Xu Y; Zhang H
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):87-8. PubMed ID: 10861111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of selected peripheral blood leukocyte functions in patients with various forms of periodontal disease.
    Pietruska M; Zak J; Wysocka J; Jaworowska B; Zelazowska B; Lipska A; Stokowska W
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):208-12. PubMed ID: 15247888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil dysfunctions, IL-8, and soluble L-selectin plasma levels in rapidly progressive versus adult and localized juvenile periodontitis: variations according to disease severity and microbial flora.
    Gainet J; Dang PM; Chollet-Martin S; Brion M; Sixou M; Hakim J; Gougerot-Pocidalo MA; Elbim C
    J Immunol; 1999 Nov; 163(9):5013-9. PubMed ID: 10528206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of periodontal treatment on IL-1beta, IL-1ra, and IL-10 levels in gingival crevicular fluid in patients with aggressive periodontitis.
    Toker H; Poyraz O; Eren K
    J Clin Periodontol; 2008 Jun; 35(6):507-13. PubMed ID: 18371054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder.
    Mehra R; Storfer-Isser A; Kirchner HL; Johnson N; Jenny N; Tracy RP; Redline S
    Arch Intern Med; 2006 Sep; 166(16):1725-31. PubMed ID: 16983050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of hygiene indices in studying the relations between oral hygiene and periodontitis based on epidemiologic studies].
    Borysewicz G
    Ann Acad Med Stetin; 1990; 36():37-48. PubMed ID: 2099107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between salivary IL-1beta levels and periodontal clinical status.
    Tobón-Arroyave SI; Jaramillo-González PE; Isaza-Guzmán DM
    Arch Oral Biol; 2008 Apr; 53(4):346-52. PubMed ID: 18155182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines in patients with ischaemic heart disease or myocardial infarction.
    Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
    Kardiol Pol; 2003 Aug; 59(8):105-14. PubMed ID: 14560325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
    Gürkan A; Cinarcik S; Hüseyinov A
    J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.